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ABSTRACT
Four cDNA clones coding for different Artemia actin
isoforms have been isolated. Three of the clones
contain the complete coding sequences while the
fourth one lacks 145 bases, coding for the 49 amino
terminal amino acids of the protein. The amino acid
sequences predicted for the four actin isoforms
identified are highly homologous to insect actins as
well as to vertebrate cytoplasmic actins. The four
identified cDNA clones code for mRNAs of 5.2, 1.9, 1.6
and 1.8 kb, respectively, whose expression is regulated
during development. Three of the actin mRNAs are
present in cryptobiotic embryos while the other is not.
The steady-state levels of all four mRNAs increase
during development to reach maximal levels by 10- 15
hours of development and decrease thereafter. The
total number of actin genes encoded in the Artemia
genome has been estimated as 8 to 10 by Southern
analysis of total DNA.
INTRODUCTION
Actin is involved in several basic functions of the organism such
as cell division, cell motility or muscle contraction (1-3). Most
organisms have genes coding for several actin isoforms
specialized to fulfill some of these functions. In mammals, for
example, two different isoforms are found in non muscular cells
(cytoplasmic actins, named ,B and -y) and four isoforms in
muscular cells (named a), two specific for striated muscles
(skeletal and cardiac) and two specific for smooth muscles
(vascular and non vascular isoforms). Although all actins isoforms
are over 90% identical to each other, in vertebrates, there is a
clear distinction in the amino acid sequences of muscular (a) and
non muscular ([B and -y) actins, specially at their amino terminus
(4).
Several actin isoforms have also been identified in
invertebrates. All invertebrate actins are more similar to
cytoplasmic than to muscular vertebrate actins so that it is not
possible to recognize invertebrate muscular actins from their
amino acid sequences(5). Nevertheless, invertebrate actin
isoforms expression is also tissue-specific and the study of the
pattern of expression of the different isoforms during embryonic
development and in adult organisms has allowed the
characterization of several muscular and cytoplasmic actins in
Drosophila (6,7), sea urchin (8) and Dictyostelium discoideum
(9).
EMBL accession nos X52602 -X52605 (incl.)
The family of actin genes is a very interesting system to study
the regulation of gene expression since highly homologous genes
of this family are expressed in different tissues and at different
stages of development (10- 13). Promotor sequences have been
characterized from muscular actins that direct muscle specific
expression when fused to reporter genes (14-16). Actually, some
regions from these promoters, like the CArG box, are also present
in other muscle specific genes (17). Promotor regions from
cytoplasmic sea urchin actins also direct tissue specific expression
of reporter genes at the proper time of development (18).
These characteristics of the actin gene family have prompted
us to approach its study in the crustacean Artemia. This organism
has been used as a model system to study embryonic development
and cryptobiosis because of its property of getting into
cryptobiosis at the gastrula stage of development under adverse
environmental conditions (19). Cryptobiosis can be reversed by
incubation of the cryptobiotic embryos (cysts) at the proper
conditions of salt, light and temperature so that the activation
of the cyst and its posterior embryonic development can be studied
in the laboratory. Artemia cysts are morphologically uniform and
during the first hours of development there is an active process
of differentiation and morphogenesis. By 15-20 hours of
incubation at 30°C swimming nauplii hatch from the cyst
presenting several well differentiated organs such as the antennae,
eye or salt gland. Further development of the nauplii involves
the formation of the intestinal track, among other thoracic and
abdominal structures, so that by about 50 hours of development
the nauplii are able to feed themselves. This can be a very useful
model system to study the regulation of gene expression since
there is no metabolic activity in the cyst and transcription is
resumed after activation of the cyst and modulated according to
the pattern of embryonic development. As a first step in this
project, we present in this report the isolation of cDNA clones
coding for four Artemia actin isoforms, their nucleotide sequence
and the variations of the steady-state levels of the mRNAs
encoded by these genes during postgastrular embryonic and early
larval development.
MATERIALS AND METHODS
Artemia culture and nucleic acid isolation
Cryptobiotic Artemia embryos (cysts) were purchased from San
Francisco Bay Brand (Neward, CA) in February, 1987. Embryos
were dechorionized and cultured as described previously (20).
RNA was isolated from cysts or nauplii cultured at 30°C for
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the period of time indicated in each experiment by the method
of Adams et al (21).
Total DNA was purified from 20-hour-old nauplii by the
method of Cruces et al (22).
Screening of cDNA libraries
A cDNA library made up from adults mRNA in the lambda
vector Xgtl 1 (23) was screened by the method of Benton and
Davis (24). A 1.8 kb long HindIll-HindIII fragment containing
the actin coding sequences from the Drosophila actin clone DmA2
(25) was labelled according to Feinberg and Vogelstein (26) and
used as probe in this screening. Filters were hybridized under
standard conditions (6 x SSC, 0.5 %SDS, 2 x Denhardt's solution,
100 ptg/mn calf thymus DNA at 65°C for 15 hours; SSC is 0.15
M-NaCl, 0.015 M-trisodium citrate, pH 7; Denhardt's solution
is 0.2 mg/ml Ficoll, type 400, 0.2 mg/ml polyvinylpyrrolidone,
0.2 mg/ml bovine serum albumin, fraction V) and washed in
2xSSC, 0.1%SDS at 650C.
One of the cDNA clones isolated in the first screening
(pArAct211) was used as probe in two more screenings of a
cDNA library made up from 20-hours-old-nauplii mRNA in the
plasmid vector pUC 18 (27). These screenings were made
according to the method of Hanahan and Meselson (28). Labelling
of the probe and hybridization and washing of the filters were
made as previously described for the first screening of the cDNA
libraries.
Northern and Southern blotting analyses
Ten micrograms of total RNA from Artemia cysts or nauplii at
different stages of development were analyzed in 1.5 %
agarose-2.2M formaldehyde gels and transferred to nylon
membranes according to Thomas (29). RNA blots were
hybridized to oligonucleotide probes labelled at their 5' end by
the enzyme polynucleotide kinase (30). Washing of the filters
was made in 6 x SSC, 0.1 % SDS, 0.05 % sodium pyrophosphate
at 370C.
For the analyses of genomic DNA, total DNA was isolated
from 20-hours-old nauplii and ten micrograms of the DNA
digested with each indicated enzyme. DNA fragments were
analyzed on 0.7% agarose gels and transferred to nylon
membranes according to the method of Reed and Mann (31).
Filters were hybridized to pArAct211 insert. Labelling of the
insert and hybridization of the filters were made under the same
conditions described for the screening of the cDNA libraries.
Washing of the filters was at 65°C in 2 xSSC, 0.1 % SDS or
0.1 x SSC, 0. 1 % SDS, as indicated for each experiment.
DNA sequencing
The nucleotide sequence of the DNA was determined by the
termination inhibitor method of Sanger et al. (32) modified by
Chen and Seeburg (33) for sequencing double-stranded DNA.
The plasmid pUC 18 (34) was used as vector for all the
constructions needed for sequencing of the cDNA clones. Either
internal restriction sites, determined by restriction mapping of
the clones, or progressive deletions of the clones made up by
the use of the Exonuclease III-Nuclease S 1 method (35) were
used to obtain the complete nucleotide sequence of both strands
of each cDNA clone.
RESULTS
Isolation of cDNA clones
The Drosophila actin gene DmA2 has been used as a probe to
isolate Artemia actin cDNA clones under low stringency
coding sequences
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Figure 1. Restriction map of Artemia actin cDNA clones. The restriction map
of the Artemia actin cDNA clones pArAct2O5 and pArAct2 1 was determined
by digestion with the indicated restriction enzymes and combinations of them
after cloning of these cDNA clones in the EcoRI site of the plasmid vector pUC 18.
The restriction map of the clones pArAct3O2 and pArAct4O3 were established
in the same way except that they were inserted in the BamHI site of the vector.
hybridization conditions. Initially, 100.000 clones of an adult
cDNA library made in the lambda vector Xgtl 1 were screened.
Four of the positive clones were chosen for characterization. The
inserts from these four clones were cloned in the EcoRI site of
the plasmid vector pUC 18. Restriction map and partial nucleotide
sequencing of these clones showed that three of them were
overlapping so that the longest of these three (pArAct2 11) and
the other clone (pArAct2O5), whose restriction maps are shown
in Figure 1, were chosen for further characterization.
The insert of the clone pArAct2 1 was used as probe for two
more screening of a second Artemia cDNA library, made from
20-hour-old nauplii mRNA and inserted in the BamHI site of
the plasmid vector pUC 18 (27). A total of 20,000 colonies of
this library were screened and 14 positive clones chosen for
characterization. Restriction mapping and terminal sequencing
of these clones showed that 8 of these clones were overlapping
with the previously isolated pArAct2 1 clone and one more with
the pArAct2O5 clone. Besides these clones, two new types of
cDNA clones were identified. Two cDNA clones were isolated
for each of these new types and the longest ones, pArAct3O2
and pArAct403 selected for characterization. The restriction map
of the cDNA clones that were selected is shown in Figure 1.
The nucleotide sequence of the four selected cDNA clones has
been established and is shown in Figure 2. Each of the four cDNA
clones contained an open reading frame whose encoded amino
acid sequences were over 90% similar to the Drosophila actin
used as probe. The nucleotide sequence of the clone pArAct2O5
is shown in Figure 2 together with the amino acid sequence
predicted from this clone. The nucleotide sequence of the other
three cDNA clones are also shown in Figure 2, underneath the
pArAct2O5 sequence. Three of the cDNA clones (pArAct2O5,
pArAct2 11 and pArAct403) contain their complete coding regions
as well as 5' and 3' untranslated sequences while the clone
pArAct3O2 is missing 145 nucleotides at its 5' end that would
code for the 49 N-terminal amino acids of the protein. Figure
2 shows that the four cDNA clones are very homologous in their
coding sequences while the homology is rather low in their
untranslated sequences, as has been shown to be the case for
clones coding for different actin isoforms from other organisms.
The amino acid sequences encoded by the four cDNA clones
are compared in Figure 3. The degree of identity between the
coding sequences of the four clones at the nucleotide and amino
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A..TA... . .
Pmst Ala Leu ValValiAspAsnGly Serily Met Cys Lys AlaG'y Pr.eAia
205 lEA GTT G1TT GAO MT OGG TCT GGA Alt; MAG lEA G110A
211 ..T.....0.OG.C..C ..T .0.CO.C..C.0
302
403 0.....c. . ... 0.0.C OC..A
........
Prot Giy Asp Asp AiaPro ArgAla Vai Phe Pro Ser 'e ValGly Arg Pro
205 OX GAT GAT CCA CE!? GCA GMG =I itt AIT-, OS OXC
211 ..A .T..CO....C.P.A..A C..A ..T
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211 ..C ... T.A ............C....T......C T.G.302 ..CO..T.G. .0C...A. O.C..A ..T .A.G..G ..CT.G..
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3302......A..A ...A .....T ..C .T..T......T
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Prot le Lys Ile Ile Ala Pro Pro Giu Arg Lys Tyr Ser Val Trp Ilie Gly205 AltT AAG Alt Alt GCEO CEA OXC GAG OCGT AM TAO =t GIT TGG Alt GOT
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Figure 2. Nucleotide sequence of the Artemia actin cDNA clones. The nucleotide sequence of the clones was determ-ined as indicated in the section Materials and
Methods. The complete nucleotide sequence of the clone pArAct2O5 is shown in the lane 205 in capital letters. The nucleotide sequence of the other cDNA clones
(lanes 211, 302 and 403) is shown underneath that of the clone pArAct2O5. A dot indicates the same nucleotide as that determined for pArAct2O5 for that position.
The amino acid sequence predicted from pArAct2O5 nucleotide sequence is shown over the nucleotide sequence of this clone (lane Prot). Numbers at the right indicate
the position of the last nucleotide of each lane (plain numbers) or the last amino acid of the lane (bold numbers).
acid levels is summarized in Table The identity between the
predicted amino acid sequences is over 94% and the identity
between the nucleotide sequences over 78%, values currentlly
found in actin isoforms. Besides, most of the amino acid
differences are conservative (Serine for Threonine, Aspartic for
Glutamic, Isoleucine for Leucine or Valine) as shown in Figure
3. The predicted N-terminal sequences are similar to other
invertebrate N-terminal sequences in that they code for
Methionine-Cysteine and three acidic amino acids in the first five
positions, a Valine at position 11I and a Cysteine at position 18
(36). These data confirm previous results obtained by peptide
analyses of total Artemia actin (5).
The amino acid sequence predicted from the four cDNA clones
has been compared to that of actin isoforms from other organisms
contained in the EMBL protein bank using the fast.p program
(37) and the degree of homology found is shown in Table IL.
Artemia actin isoforms show a similar degree of homology to
insect actins and to vertebrate cytoplasmic actins. The degree
of homology with vertebrate muscular actins is lower, in
agreement with the results obtained for other invertebrate actin
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Figure 3. Comparison of the amino acid sequences coded for Artemia cDNA
clones. The amino acid sequence predicted from the nucleotide sequence of the
clone pArAct2O5 is shown in the upper lane (labelled as 205) using the one letter
amino acid designation system. The predicted sequences coded by the clones
pArAct2l1 (lane 211), pArAct3O2 (lane 302) and pArAct 403 (lane 403) are
shown underneath. Dots indicate the presence of an amino acid identical to the
one coded by pArAct2O5 at that position.
Table I. Comparison of the nucleotide sequences of the coding regions of Artemia
actin cDNA clones and their predicted amino acid sequences.
% Protein homology
205 211 302 403
205 --- 98.4 94.5 97.1
211 85.5 --- 94.8 97.1
302 79.2 78.7 --- 96.6
403 80.1 80.3 78.9 ---
% Nucleotide identity
genes (36). The protein coded by the clone pArAct4O3 is
consistently more similar to actins from other organisms than
the ones coded by the other clones.
Expression of actin isoforms during Artemia development
In order to analyze the steady-state levels of the mRNAs coded
by the actin cDNA clones that we have isolated, oligonucleotide
probes were designed that specifically hybridize to each of the
clones. The use of oligonucleotide probes was necessary given
the high homology of the coding regions of the cDNAs and the
small length of the untranslated regions of some of the clones
(for example, clone pArAct3O2). The oligonucleotide probes
were complementary to 3' untranslated sequences of the clones
and their names and sequences are as follow:
Act-1: CACACCAAAGTAACCAGTCA, complementary to
nucleotides 1394 to 1413 of the clone pArAct2O5.
Act-2: GATCTAGATACAGGAGCCCT, complementary to
nucleotides 1285 to 1304 of the clone pArAct21 1.
Act-3: CGGGCAAGTCATTTAGAATG, complementary to
nucleotides 1005 to 1024 of the clone pArAct3O2.
Act-4: GGCCGTTAATCATCTTTCAAC, complementary to
nucleotides 1198 to 1218 of the clone pArAct4O3.
The specificity of each oligonucleotide was tested by
hybridization of every oligonucleotide probe to the insert of each
of the four cDNA clones (data not shown).
Total RNA was obtained from Artemia cysts or nauplii at
different stages of development and analyzed for the presence
of the mRNA encoded by each actin isoform. The results of these
experiments are shown in Figure 4. The amount of probe
hybridized to each RNA lane was quantified by densitometry of
the autoradiograms and divided by the amount of ribosomal RNA
present in that lane, quantified by ethidium bromide staining of
the gels. The amount of ribosomal RNA was used to correct
possible differences in the amount of RNA applied to each lane
and because it has been shown that the amount of ribosomal RNA
present per cell does not change during the period of development
that we have studied in Artemia (38). The normalized quantity
of the mRNAs expressed at different stages of development are
shown in Figure 5. Hatching of 50% of the Artemia nauplii took
place by 15 hours of incubation at 30'C in these experiments.
The clone pArAct2O5 (probe Act-1) hybridizes to a 5.2 kb long
mRNA present in cryptobiotic embryos whose steady-state level
increase more than twice by 10-15 hours of development to
come back to cyst levels at later stages of development. Clones
pArAct211 and pArAct403 (probes Act-2 and Act-4) code for
mRNAs of 1.9 and 1.8 kb, respectively and follow a similar
pattern of expression during development: both are expressed
at low levels in cryptobiotic embryos, their steady-state levels
increase over five times to reach maximal values by 10-15 hours
Table II. Comparison of the amino acid sequences of Artemia actin isoforms with those of other organisms.
Actin origin Homology Number of
sequences
pArAct205 pArAct2l1 pArAct302 pArAct403
Insects 95.8 96.1 95.3 96.5 3
Vertebrate a 92.4 92.6 92.3 93.7 13
Vertebrate ,B 95.7 96.1 96.0 97.8 4
Vertebrate y 95.3 95.6 96.0 97.4 2
D. discoideum 92.1 92.6 93.4 94.4 3
Yeast 88.1 88.1 88.4 89.7 2
Plants 83.1 83.7 85.3 85 4
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of development and decrease there after. In contrast, the steady-
state levels of the mRNA coded by the clone pArAct302 (probe
Act-3), which is 1.6 kb long, follow a more complex pattern.
This mRNA is not present in cryptobiotic embryos, it is induced
by ten hours of development and follows an oscillatory pattern
of expression during development, with maximal expression by
15, 30 and 50 hours of development. These results were
confirmed by dot-blot analyses (data non shown).
Number of actin genes present in Artemia
The number of genes coding for actin in the Artemia genome
was estimated by Southern blot analyses. Total DNA from
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20-hours-old nauplii was prepared and digested with the
restriction enzymes BamHI, EcoRI, HindI or PstI, as indicated
in Figure 6. Ten micrograms ofDNA digested with each enzyme
were electrophoresed on 0.7% agarose gels. The DNAs were
transferred to nylon membranes that were hybridized with the
pArAct2l1 clone insert. Duplicate filters were washed at 65°C
with either 0.1 x SSC, 0.1% SDS or 2 xSSC, 0.1 %SDS, as
indicated. Under high stringency conditions (0.1 x SSC) only one
or two major bands of hybridization were observed (Figure 6)
while under low stringency conditions (2 x SSC) 10 to 12 bands
gave similar hybridization signals in each lane. These data suggest
the presence of an approximated number of eight to ten genes
coding for actin in Artemia.
DISCUSSION
Artemia cDNA clones coding for four different isoforms of actin
have been characterized. Their nucleotide sequences show a high
homology between their coding sequences and those of other
vertebrate and invertebrate actins. The higher homology is found
between Artemia actins, insect actins and vertebrate cytoplasmic
actins. Further more, the N-terminal amino acid sequence
predicted from three of the Artemia cDNA clones show the
characteristic features of other invertebrate actins: Cysteine at
._
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Figure 4. Expression of actin isoforms during Artemia development. Ten
micrograms of total RNA from cryptobiotic embryos (lane 0) or cysts or nauplii
incubated for 5 to 50 hours at 30°C (lanes 5 to 50, respectively) were analyzed
in 1.5%-agarose-2.2M-formaldehyde gels, transferred to nylon membranes and
hybridized to the following oligonucleotide probes: A. Oligonucleotide Act-1,
complementary to clone pArAct2O5. B. Oligonucleotide Act-2, complementary
to the clone pArAct21 1. C. Oligonucleotide Act-3, complementary to the clone
pArAct3O2. D. Oligonucleotide Act-4, complementary to the cDNA clone pArAct
403. The position in the gel of ribosomal RNAs obtained from rat (28S and 18S)
and E. coli (23S and 16S) is indicated on lane M.
Figure 5. Quantification of the actin isoforms expression during Artemia
development. The hybridization of the actin oligonucleotide probes to total RNA
from different stages of Artemia development, shown in Figure 4, was quantified
by densitometry of the autoradiograms. The amount of hybridization was corrected
by the amount of ribosomal RNA present in each sample, as determined by
ethidium bromide staining of the gels, and is given in arbitrary units. A.
Oligonucleotide Act-1, complementary to clone pArAct2O5. B. Oligonucleotide
Act-2, complementary to the clone pArAct21 1. C. Oligonucleotide Act-3,
complementary to the clone pArAct3O2. D. Oligonucleotide Act-4, complementary
to the cDNA clone pArAct 403.
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Figure 6. Detection of actin sequences in Artemia DNA. Ten micrograms of
20-hours-old nauplii DNA were digested with BamHI (lanes B), EcoRI (lanes
E), HindI (lanes H) or PstI (lanes P), analyzed on 0.7% agarose gels, transferred
to nylon membranes and hybridized with labelled pArAct2lI insert DNA.
Duplicate filters were washed at 65°C with either 2 xSSC, 0. % SDS (2 x SSC
lanes) or 0. 1 x SSC, 0. 1% SDS (0. 1 x SSC lanes). The position and size of the
fragments originated by HindlIl digestion of lambda DNA is indicated.
the second amino acid position followed by three acidic amino
acids, Valine at position 11, Methionine at position 17 and
Cysteine at position 18 (36). The similarity of the N-terminal
peptide of Artemia with those of other invertebrate and
cytoplasmic vertebrate actins had been reported from paper
electrophoretic analyses of the major N-terminal peptide obtained
from total actin population of adult animals (5). The data
presented in this report confirm these findings for three specific
actin isoforms and extend the analyses to the complete sequence
of the proteins. To our knowledge, these are the first complete
amino acid sequences to be reported for crustacean actins. The
analysis of the N-terminal peptide, together with the results
presented in this article, also show that post-translational
processing of actin is similar in Artemia to other organisms,
involving the removal of the N-terminal Methionine and Cysteine
and the the acetylation of the N-terminal Aspartic acid residue.
The existence of the enzymatic machinery necessary to achieve
these processing reactions has been previously demonstrated both
in muscular and non muscular cells(39).
The comparison of the nucleotide and predicted amino acid
sequences of the Artemia actin clones shows that the most
homologous clones are pArAct2O5 and pArAct211 (98.4
homology at the amino acid level and 85.5 identity at the
nucleotide level). Despite the high level of conservation of the
coding regions, there is no significant conservation of the
untranslated regions of the different isoforms, not even between
pArAct2O5 and pArAct2 11. These data would suggest that the
different Artemia actin isoforms diverged long time ago, in
contrast to the situation described for some sea urchin actin
isoforms that seems to have diverged so recently that their
untranslated and intron sequences are highly homologous and the
genes are contiguous in the genome (40).
Artemia actin isoforms pArAct2O5, 211 and 302 show a similar
degree of homology with insect and cytoplasmic vertebrate actins
while pArAct4O3 is even more homologous to vertebrate ( and
y isoforms than to insect isoforms. These data suggest that
crustacea and insects diverged soon after the evolutive separation
of vertebrates and invertebrates. These results are in good
agreement with the filogenetic trees that have been derived from
the comparison to vertebrates, than the comparison of globin (41)
or ribosomal RNA (42) sequences.
The number of actin genes encoded in the Artemia genome
has been roughly estimated in 8 to 10 by Southern analyses. The
number of genes estimated for Artemia would be intermediate
between the six genes existing in Drosophila (7) and the 15 genes
reported in sea urchin (43) and D.discoideum (44).
The study of the expression of the actin mRNAs during
development is of particular interest since the pattern of RNA
synthesis during the embryonary stage of Artemia development
is poorly understood. This fact is the consequence of two
circumstances: 1. Artemia cysts are impermeable to radioactive
precursors. 2. There are very few studies published on the
expression of different genes during Artemia development (19).
The data obtained in this report indicate an important increase
in the steady-state level of the actin mRNAs between 5 and 10
hours after activation of the cyst. Similar increases in steady-
state levels of Na/K and Ca ATPase mRNAs have also been found
between 5 and 10 hours of development (23, 45). These results
suggest an important transcriptional activity between 5 and 10
hours of development. The establishment of the existence of this
period of active transcription is of great interest since comparison
of this situation with the opposite, represented by the cyst, where
no transcription takes place, can be very helpful to study the
mechanisms that regulate the inhibition of transcription in the
cyst and its resumption after cyst activation.
Further studies would be required in order to characterize the
tissue-specific expression of each of the actin isoforms coded by
the cDNA clones. In particular, the use of the specific
oligonucleotides probes in 'in situ' hybridization experiments
could be very informative. On the other hand, the isolation of
actin cDNA clones makes possible the identification of their
genomic clones and the characterization of the promoter
sequences that regulate their expression during Artemia cyst
activation and embryonic development. These topics are currently
under study in our laboratory.
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